Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgical Excision Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma: an Open, Non-inferiority, Randomized Controlled Trial

NCT02242929 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02242929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02242929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgical Excision Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma: an Open, Non-inferiority, Randomized Controlled Trial
Lead sponsor
Maastricht University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2022
Enrollment
145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nodular basal cell carcinoma